Share

January 07, 2020; 94 (1) Article

NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population

Yi-Chung Lee, Chih-Ping Chung, Ming-Hong Chang, Shuu-Jiun Wang, Yi-Chu Liao
First published December 2, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008700
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
256

Share

Article Information

vol. 94 no. 1 e87-e96
DOI: 
https://doi.org/10.1212/WNL.0000000000008700
PubMed: 
31792094
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 17, 2019
  • Accepted in final form June 27, 2019
  • First Published December 2, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Yi-Chung Lee, MD, PhD,
    2. Chih-Ping Chung, MD, PhD,
    3. Ming-Hong Chang, MD,
    4. Shuu-Jiun Wang, MD, PhD and
    5. Yi-Chu Liao, MD, PhD
  1. Yi-Chung Lee, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) World Congress of Neurology 2017, speaker honoraria, USD$1000 (2)The Asian Oceanian Congress of Neurology 2018, speaker honoraria, USD$800

    Editorial Boards:

    1. (1) Acta Neurologica Taiwanica, Acting Editor, 2012 till now

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Ministry of Science and Technology, Taiwan, 105-2628-B-075 -002 - MY3, Principal investigator, 2016/8-2019/7 (2) Ministry of Science and Technology, Taiwan, 107-2314-B-075 -014 - MY3, Principle investigator, 2018/8-2021/7 (3)Ministry of Science and Technology, Taiwan, 108-2312-B-075 -001,Principle investigator, 2019/1-2019/12

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Taiwan Motor Neuron Disease Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Chih-Ping Chung, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ming-Hong Chang, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Shuu-Jiun Wang, MD, PhD and
    5. Scientific Advisory Boards:

    1. (1) Allergan (Commercial) (2) Eli Lilly (Commercial) (3) Daiichi-Sankyo (Commercial) (4) Norvastis Taiwan (Commercial)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Pfizer Taiwan (Speaking honoraria, commercial) (2) Eli Lilly Taiwan (Speaking honoraria, commercial) (3) GSK Taiwan (Speaking honoraria, commercial)

    Editorial Boards:

    1. Editor, Journal of the Chinese Medical Association, 2005- Associate editor, Cephalalgia, 2009- Associate editor for headache, MedLink Neurology, 2009- Associate editor, Headache, 2013- Associate editor, Journal of Headache and Pain, 2012-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Ministry of Science and Technology of Taiwan [MOST 107- 2321-B-010-001,MOST 106-2321-B-010-009-, MOST 106-2314-B- 010 -019 -MY2] (2) Ministry of Health and Welfare, Taiwan [MOHW 107-TDU-B- 211-123001, MOHW 108-TDU-B-211-133001] (2) Taipei-Veterans General Hospital [V108C-105, V107C-13] (3) Brain Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Taiwan Headache Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Yi-Chu Liao, MD, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (Y.-C. Lee, C.-P.C., S.-J.W., Y.-C. Liao), Taipei Veterans General Hospital; Department of Neurology (Y.-C. Lee, C.-P.C., M.-H.C., S.-J.W., Y.-C. Liao) and Brain Research Center (Y.-C. Lee, S.-J.W., Y.-C. Liao), National Yang-Ming, University School of Medicine, Taipei; and Department of Neurology (M.-H.C.), Taichung Veterans General Hospital, Taiwan.
  1. Correspondence
    Dr. Liao ycliao5{at}vghtpe.gov.tw
View Full Text

Article usage

Article usage: November 2019 to April 2022

AbstractFullPdfSource
Nov 2019100Highwire
Dec 2019581837Highwire
Jan 20204854725Highwire
Feb 2020105911Highwire
Mar 2020110216Highwire
Apr 2020166320Highwire
May 202080212Highwire
Jun 202083111Highwire
Jul 2020112611Highwire
Aug 20205315Highwire
Sep 202096511Highwire
Oct 202010254Highwire
Nov 202084413Highwire
Dec 2020733720Highwire
Jan 202115767Highwire
Feb 202113404Highwire
Mar 202121108Highwire
Apr 202112166Highwire
May 202111085Highwire
Jun 202112224Highwire
Jul 20219112Highwire
Aug 202110722Highwire
Sep 20219213Highwire
Oct 202110517Highwire
Nov 202110575Highwire
Dec 202110800Highwire
Jan 20229112Highwire
Feb 202210731Highwire
Mar 202210551Highwire
Apr 202211153Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me